Cholesterol depletion with physiological concentrations of a statin decreases the formation of the Alzheimer amyloid Aβ peptide

Journal of Alzheimer's Disease

Volumn 3, Issue 2, 2001, Pages 221-229

  Buxbaum, Joseph D ^a   Geoghagen, Neil S M ^a   Friedhoff, Lawrence T ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Aura Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DRUG MECHANISM; HYPERCHOLESTEROLEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RISK FACTOR; SULFATION;

EID: 0034990260     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2001-3207     Document Type: Article

References (26)

1. Contribution of cysteine 158, the glycosylation site threonine 194, the amino- and carboxy-terminal domains of apolipoprotein E in the binding to amyloid peptide β (1-40)
2. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
3. Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures
4. Processing of Alzheimer β/A4 amyloid precursor protein: Modulation by agents that regulate protein phosphorylation
5. Evidence that tumor necrosis factor a converting enzyme is involved in regulated a-secretase cleavage of the Alzheimer amyloid protein precursor
6. Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner
7. Broeckhoven, Molecular genetics of Alzheimer's disease
8. β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease
9. Amyloid, the presenilins and Alzheimer's disease
10. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease
11. Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease
12. High levels of circulating Aβ42 are sequestered by plasma proteins in Alzheimer's disease
13. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease
14. Human blood-brain barrier receptors for Alzheimer's amyloid-β 1-40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer
15. Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid β peptide in aged squirrel monkey with cerebral amyloid angiopathy
16. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
17. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
18. β-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: Relevance to Alzheimer's disease
19. Receptor-mediated transport of human amyloid β-protein 1-40 and 1-42 at the blood-brain barrier
20. Alzheimer's disease: Genetic studies and transgenic models
21. APOE genotypeplasma lipids, lipoproteins, and AD in community elderly
22. Immunization with amyloid-b attenuates Alzheimer-disease-like pathology in the PDAPP mouse
23. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons
24. Cellular mechanisms of β-amyloid production and secretion
25. β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmenbrane aspartic protease BACE
26. Apolipoprotein E promotes the binding and uptake of β-amyloid into Chinese hamster ovary cells in an isoform-specific manner